Skip to main content

Bright Peak Therapeutics

Allschwil, Switzerland

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

$90.0M raised
Jun 2024
Series C

Top Investors

BlackRockVenrockRA Capital ManagementVersant VenturesNorthleaf Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bright Peak Therapeutics

How much funding has Bright Peak Therapeutics raised?
Bright Peak Therapeutics has raised $90.0M in total funding. The most recent round was Series C. The last funding was announced in June 2024.
Who are Bright Peak Therapeutics's investors?
Bright Peak Therapeutics's investors include BlackRock, Venrock, RA Capital Management, Versant Ventures, Northleaf Capital Partners.
Where is Bright Peak Therapeutics headquartered?
Bright Peak Therapeutics is headquartered in Allschwil, Switzerland.
What does Bright Peak Therapeutics do?
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
What stage is Bright Peak Therapeutics at?
Bright Peak Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Bright Peak Therapeutics — Funding & Investors." VCBacked, June 11, 2024, https://www.vcbacked.co/company/bright-peak-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Bright Peak Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/bright-peak-therapeutics
Wikipedia (cite web)
{{cite web |title=Bright Peak Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bright-peak-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .